Merck EBIT 2010-2024 | MRK

Merck EBIT for the quarter ending December 31, 2024 was $4.347B, a 353.91% decline year-over-year.

  • Merck 2024 EBIT was 20.221B, a 584.53% increase from 2023.
  • Merck 2023 EBIT was 2.954B, a 83.84% decline from 2022.
  • Merck 2022 EBIT was 18.282B, a 38.51% increase from 2021.

EBIT can be defined as earnings before interest and taxes.

Merck EBIT 2010-2024 | MRK

  • Merck 2024 EBIT was 20.221B, a 584.53% increase from 2023.
  • Merck 2023 EBIT was 2.954B, a 83.84% decline from 2022.
  • Merck 2022 EBIT was 18.282B, a 38.51% increase from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B